Papers
6
Total Citations
123
H-Index
5
About
Dr. Zhigang Ji is a pioneering urologic surgeon and researcher at the forefront of robotic surgery innovation, with a primary focus on developing and validating next-generation surgical robotic systems. His most significant contributions center on the clinical translation of the KangDuo Surgical Robot (KD-SR), a domestically developed Chinese robotic platform designed to compete with the established da Vinci system. In a landmark double-center prospective randomized controlled noninferiority trial (2022, 54 citations), Dr. Ji demonstrated that the KD-SR is as safe and effective as the da Vinci Si for robot-assisted partial nephrectomy, a critical step toward reducing surgical costs and expanding access. He further advanced the field by proving the feasibility of dual-console telesurgery using 5G and wired networks (2023, 26 citations), a breakthrough with profound implications for remote surgical care, especially highlighted during the COVID-19 pandemic. Dr. Ji has also established the safety and efficacy of the KD-SR-01 system for partial adrenalectomy (2023, 15 citations) and radical prostatectomy (2024, 8 citations), systematically expanding the platform’s applications. His work is not only technically rigorous but also addresses pressing global needs for affordable, high-quality surgical technology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6